Mohit Tissues Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 1.51 Cr
- Company Age 4 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 14.15 Cr
- Revenue Growth %
- Profit Growth 573.76%
- Ebitda 5745.18%
- Net Worth 100.87%
- Total Assets 115.23%
About Mohit Tissues
Mohit Tissues Private Limited (MTPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 May 2020 (Four years and nine months 4 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 1.51 Cr.
The company currently has active open charges totaling ₹14.15 Cr.
Sandeep Jain, Anju Jain, and Arvind Kumar serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21098DL2020PTC363922
- Company No.
363922
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Mohit Tissues?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Jain  | Director | 23-May-2020 | Current |
| Anju Jain | Director | 23-May-2020 | Current |
| Arvind Kumar | Director | 30-Dec-2021 | Current |
Financial Performance of Mohit Tissues.
Mohit Tissues Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 573.76% increase in profit. The company's net worth Soared by an impressive increase of 100.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mohit Tissues?
Unlock access to Mohit Tissues's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mohit Paper Mills LimitedSandeep Jain and Anju Jain are mutual person
Centurion Industries Private LimitedAnju Jain is a mutual person
Charges (Loans)
₹14.15 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 14.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Jul 2024 | Others | ₹1.50 M | Open |
| 08 Nov 2021 | Others | ₹14.00 Cr | Open |
How Many Employees Work at Mohit Tissues?
Unlock and access historical data on people associated with Mohit Tissues, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mohit Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mohit Tissues's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.